One-year outcome of small-vessel disease treated with sirolimus-eluting stents: a subgroup analysis of the e-SELECT registry.
暂无分享,去创建一个
M. Jeong | S. Ellis | V. Džavík | P. Urban | C. Spaulding | A. Abizaid | A. Banning | A. Bartorelli | R. Gao | V. Legrand
[1] Jennifer Taylor. The Journal of Interventional Cardiology. , 2012, European heart journal.
[2] S. Ellis,et al. One-year clinical outcomes after sirolimus-eluting coronary stent implantation for acute myocardial infarction in the worldwide e-SELECT registry. , 2012, Journal of interventional cardiology.
[3] F. Neumann,et al. The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry. , 2012, JACC: Cardiovascular Interventions.
[4] M. Jeong,et al. Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[5] M. Jeong,et al. Sirolimus-eluting coronary stents in octogenarians: a 1-year analysis of the worldwide e-SELECT Registry. , 2011, JACC. Cardiovascular interventions.
[6] M. Jeong,et al. Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registry. , 2011, Journal of the American College of Cardiology.
[7] J. Popma,et al. A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: the PERSEUS Small Vessel trial. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[8] L. Sim,et al. Long-term outcomes after coronary bare-metal-stent and drug-eluting-stent implantations: a ‘real-world’ comparison among patients with diabetes with diffuse small vessel coronary artery disease , 2011, Coronary artery disease.
[9] J. Hermiller,et al. Percutaneous coronary intervention for small-vessel coronary disease: highlight on the everolimus-eluting stent , 2010, Expert review of cardiovascular therapy.
[10] Patrick W Serruys,et al. An everolimus‐eluting stent versus a paclitaxel‐eluting stent in small vessel coronary artery disease: A pooled analysis from the SPIRIT II and SPIRIT III trials , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[11] G. Biondi-Zoccai,et al. Percutaneous coronary intervention for small vessel coronary artery disease. , 2010, Cardiovascular revascularization medicine : including molecular interventions.
[12] D. Capodanno,et al. Sirolimus versus paclitaxel-eluting stents in small coronary vessels: long-term outcomes from a single-center registry , 2010, Journal of cardiovascular medicine.
[13] P. Fitzgerald,et al. Sirolimus-eluting stent implantation in small coronary arteries: a three dimensional intravascular ultrasound study from the SIRIUS trial. , 2010, International journal of cardiology.
[14] H. Ackermann,et al. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter , 2010, Clinical Research in Cardiology.
[15] G. Stone,et al. Clinical and angiographic comparison of everolimus-eluting and paclitaxel-eluting stents in small coronary arteries: a post hoc analysis of the SPIRIT III randomized trial. , 2009, American heart journal.
[16] F. Eberli,et al. Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy. , 2009, JACC. Cardiovascular interventions.
[17] R. Jabara,et al. Clinical and Angiographic Features of Small Vessel Stenting in the Drug‐Eluting Stent Era , 2009, Clinical cardiology.
[18] H. Izawa,et al. Safety and efficacy of 2.5-mm sirolimus-eluting stent implantation at lower deployment pressures in very small vessels (<2.5 mm) , 2009, Coronary artery disease.
[19] D. Baim,et al. Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program. , 2008, JACC. Cardiovascular interventions.
[20] E. Romagnoli,et al. Clinical and angiographic follow-up of small vessel lesions treated with paclitaxel-eluting stents (from the TRUE Registry). , 2008, The American journal of cardiology.
[21] K. Kadota,et al. The impact of lesion length and vessel size on outcomes after sirolimus-eluting stent implantation for in-stent restenosis , 2007, Heart.
[22] R. Antolín,et al. Fracaso en la implantacin de stent liberadores de frmacos. Frecuencia y factores relacionados , 2007 .
[23] F. Eberli,et al. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial. , 2007, Journal of the American College of Cardiology.
[24] A. Colombo,et al. Drug-Eluting Stent Update 2007: Part III: Technique and Unapproved/Unsettled Indications (Left Main, Bifurcations, Chronic Total Occlusions, Small Vessels and Long Lesions, Saphenous Vein Grafts, Acute Myocardial Infarctions, and Multivessel Disease) , 2007, Circulation.
[25] A. Colombo,et al. Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment , 2007, Circulation.
[26] J. E. Sousa,et al. Small coronary arteries treated with sirolimus-eluting stents: one-year results of the PORTO multicentre registry. , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[27] C. Di Mario,et al. Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE) Study. , 2007, International journal of cardiology.
[28] Seung‐Jung Park,et al. Factors predictive of cardiac events and restenosis after sirolimus‐eluting stent implantation in small coronary arteries , 2007, Catheterization and cardiovascular interventions.
[29] P. Serruys,et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.
[30] B. Xu,et al. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent. , 2007, Chinese medical journal.
[31] J. E. Sousa,et al. Anatomical and physiologic assessments in patients with small coronary artery disease: final results of the Physiologic and Anatomical Evaluation Prior to and After Stent Implantation in Small Coronary Vessels (PHANTOM) trial. , 2007, American heart journal.
[32] P. Serruys,et al. Two‐year clinical outcome after coronary stenting of small vessels using 2.25‐mm sirolimus‐ and paclitaxel‐eluting stents: Insight into the RESEARCH and T‐SEARCH registries , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[33] R. H. Hernández Antolín,et al. [Failure in the implantation of drug eluting stents. Frequency and related factors]. , 2007, Medicina intensiva.
[34] Hong Wang,et al. Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial. , 2006, The American journal of cardiology.
[35] J. Ottervanger,et al. Comparison between stenting and balloon angioplasty in patients undergoing primary angioplasty of small coronary vessels. , 2006, American heart journal.
[36] A. Kastrati,et al. Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents. , 2006, Journal of the American College of Cardiology.
[37] S. Steinhubl,et al. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. , 2006, The New England journal of medicine.
[38] A. Kastrati,et al. Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents , 2006, Circulation.
[39] S. Windecker,et al. Sirolimus-eluting coronary stents in small vessels. , 2006, American heart journal.
[40] B. Xu,et al. Comparison of drug-eluting stent and bare-mental stent in the complex small vessel intervention. , 2006, Chinese medical journal.
[41] Mattos La,et al. Análise comparativa da hiperplasia intimal após o implante de stents com e sem sirolimus em artérias coronárias de pequeno calibre , 2006 .
[42] A. Kastrati,et al. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. , 2006, European heart journal.
[43] F. Feres,et al. [Comparative analysis of intimal hyperplasia after sirolimus-eluting stent and thin-strut bare-metal stent implantation in small coronary arteries]. , 2006, Arquivos brasileiros de cardiologia.
[44] E. Bramucci,et al. Effect of sirolimus-eluting stent in diabetic patients with small coronary arteries (a SES-SMART substudy). , 2005, The American journal of cardiology.
[45] Gregg W Stone,et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. , 2005, JAMA.
[46] P. Serruys,et al. One-year clinical outcome after coronary stenting of very small vessels using 2.25 mm sirolimus- and paclitaxel-eluting stents: a comparison between the RESEARCH and T-SEARCH registries. , 2005, The Journal of invasive cardiology.
[47] G. Breithardt,et al. Relationship of Late Loss in Lumen Diameter to Coronary Restenosis in Sirolimus-Eluting Stents , 2005, Circulation.
[48] D. Holmes,et al. The approach to small vessels in the era of drug-eluting stents. , 2005, Reviews in cardiovascular medicine.
[49] E. Bramucci,et al. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. , 2004, JAMA.
[50] Y. Ikari,et al. Cutting balloon angioplasty is superior to balloon angioplasty or stent implantation for small coronary artery disease , 2004, Coronary artery disease.
[51] David J Cohen,et al. Stent Thrombosis After Successful Sirolimus-Eluting Stent Implantation , 2004, Circulation.
[52] J. Popma,et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). , 2004, Journal of the American College of Cardiology.
[53] Iijima Raisuke,et al. Predictors of restenosis after implantation of 2.5 mm stents in small coronary arteries. , 2004, Circulation journal : official journal of the Japanese Circulation Society.
[54] William Wijns,et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) , 2003, The Lancet.
[55] A. Kastrati,et al. Predictive factors for early cardiac events and angiographic restenosis after coronary stent placement in small coronary arteries. , 2002, Journal of the American College of Cardiology.
[56] M. Borggrefe,et al. Role of vessel size as a predictor for the occurrence of in-stent restenosis in patients with diabetes mellitus. , 2001, The American journal of cardiology.
[57] K. Hung,et al. Acute and long‐term outcomes of stenting in coronary vessel > 3.0 mm, 3.0–2.5 mm, and < 2.5 mm , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[58] T. Feldman,et al. Acute and late outcome after use of 2.5‐mm intracoronary stents in small (< 2.5 mm) coronary arteries , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[59] M. Hadamitzky,et al. Vessel size and long-term outcome after coronary stent placement. , 1998, Circulation.
[60] J. Birkmeyer,et al. Effect of coronary artery diameter in patients undergoing coronary bypass surgery. Northern New England Cardiovascular Disease Study Group. , 1996, Circulation.
[61] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.